About This Policy Commission

The HPC’s mandate is to drive multi-sectoral collaboration to improve Nigeria's healthcare system. It focuses on developing and advocating for evidence-based policies that strengthen health systems, promote Universal Health Coverage (UHC), enhance service delivery, and ensure the equitable distribution of healthcare resources. The HPC also works to align Nigeria’s health sector policies with international best practices and global health goals. 

Milestones & Current Intiatives

• The Health Policy Commission (HPC), in contributing to the government’s efforts to reform the health sector developed a White Paper titled Enhancing Local Production of Medicines and Vaccines in Nigeria. The paper examined the pharmaceutical industry in Nigeria, discussed critical constraints in the sector and identified enablers of local manufacturing. In addition to proffering recommendations to enhance local manufacturing, the White paper also highlighted the support required from the government, development partners, and other stakeholders.
• The HPC engaged the Federal Ministry of Health, the National Institute for Pharmaceutical Research and Development (NIPRD) and other relevant stakeholders with the White Paper on Enhancing the Local Production of Medicines and Vaccines.
• The HPC, at the Stakeholders Meeting for the Development of the National Strategic Plan for the Nigeria Pharmaceutical Sector, organised by the Federal Ministry of Health, presented findings and recommendations based on the HPC’s review of the Nigeria Vaccines Policy 2021 and the aforementioned White Paper.
• The Federal Ministry of Health has invited the HPC to collaborate on developing the National Strategic Plan for the Nigerian Pharmaceutical Manufacturing sector.
• The HPC engaged the Federal Ministry of Health with a review of the Nigeria Vaccine Policy (2021) document and offered recommendations.
• The HPC submitted two policy memos to the Health Reform Committee chaired by the Vice President, Prof. Yemi Osinbajo. The first memo was a brief report on Enhancing the Local Production of Medicines and Vaccines in Nigeria based on the White Paper mentioned above. The second memo focused on Healthcare Financing in Nigeria: Realities, Impediments & Recommendations. The submission was in response to a Call for Memoranda by the Committee.
• The Health as a Business Thematic Group developed a report on Attracting Funding for the Nigerian Health Sector: A Guide for Investors, Promoters, and Analysts Outlining the Opportunities, Financing Options, and Challenges. It outlines the opportunities in the African/Nigerian healthcare space, the challenges, and sources of financing.